Atria Investments LLC Gilead Sciences, Inc. Transaction History

Atria Investments LLC

$7.56 Billion
Q3 2024

A detailed history of Atria Investments LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Atria Investments LLC holds 82,645 shares of GILD stock, worth $7.76 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

82,645

Previous 86,499 4.46%

Holding current value

$7.76 Million

Previous $5.93 Million 16.73%

% of portfolio

0.09%

Previous 0.08%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$66.59 - $83.99 $256,637 - $323,697	-3,854 Reduced 4.46%	82,645 $6.93 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $190,460 - $219,806	-3,016 Reduced 3.37%	86,499 $5.93 Million
Q1 2024 May 21, 2024	BUY	$71.58 - $87.29 $895,251 - $1.09 Million	12,507 Added 16.24%	89,515 $6.56 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $306,415 - $347,482	4,182 Added 5.74%	77,008 $6.24 Million
Q3 2023 Nov 07, 2023	SELL	$73.94 - $80.67 $35,860 - $39,124	-485 Reduced 0.66%	72,826 $5.46 Million
Q2 2023 Aug 04, 2023	SELL	$76.01 - $86.7 $550,844 - $628,314	-7,247 Reduced 9.0%	73,311 $5.65 Million
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $2.57 Million - $2.92 Million	-33,190 Reduced 29.18%	80,558 $6.68 Million
Q4 2022 Jan 31, 2023	SELL	$62.32 - $89.47 $471,263 - $676,572	-7,562 Reduced 6.23%	113,748 $9.77 Million
Q3 2022 Nov 01, 2022	BUY	$59.54 - $68.01 $525,619 - $600,392	8,828 Added 7.85%	121,310 $7.48 Million
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $1.25 Million - $1.4 Million	21,602 Added 23.77%	112,482 $6.95 Million
Q1 2022 May 02, 2022	BUY	$57.92 - $72.58 $908,996 - $1.14 Million	15,694 Added 20.87%	90,880 $5.4 Million
Q4 2021 Feb 04, 2022	BUY	$64.88 - $73.64 $51,709 - $58,691	797 Added 1.07%	75,186 $5.46 Million
Q3 2021 Nov 16, 2021	BUY	$67.69 - $73.03 $89,012 - $96,034	1,315 Added 1.8%	74,389 $5.2 Million
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $185,649 - $202,848	2,925 Added 4.17%	73,074 $5.03 Million
Q1 2021 May 11, 2021	BUY	$60.0 - $68.46 $442,800 - $505,234	7,380 Added 11.76%	70,149 $4.53 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $909,175 - $1.04 Million	16,049 Added 34.35%	62,769 $3.66 Million
Q3 2020 Nov 05, 2020	SELL	$62.1 - $78.08 $2.83 Million - $3.56 Million	-45,649 Reduced 49.42%	46,720 $2.95 Million
Q2 2020 Sep 22, 2020	BUY	$72.34 - $84.0 $6.68 Million - $7.76 Million	92,369 New	92,369 $7.11 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $2.55 Million - $3.26 Million	-40,658 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $437,009 - $480,695	7,092 Added 21.13%	40,658 $2.64 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $113,268 - $125,028	-1,812 Reduced 5.12%	33,566 $2.13 Million
Q2 2019 Aug 26, 2019	BUY	$61.87 - $69.38 $2.19 Million - $2.45 Million	35,378 New	35,378 $2.24 Million
Q2 2019 Aug 09, 2019	SELL	$61.87 - $69.38 $946,054 - $1.06 Million	-15,291 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $162,077 - $181,569	2,592 Added 20.41%	15,291 $994,000
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $1.62 Million - $2.12 Million	-26,786 Reduced 67.84%	12,699 $794,000
Q3 2018 Oct 09, 2018	SELL	$71.28 - $78.92 $465,173 - $515,031	-6,526 Reduced 14.18%	39,485 $3.05 Million
Q2 2018 Jul 13, 2018	SELL	$64.88 - $75.68 $1.33 Million - $1.55 Million	-20,520 Reduced 30.84%	46,011 $3.26 Million
Q1 2018 Apr 30, 2018	SELL	$72.84 - $88.8 $196,595 - $239,671	-2,699 Reduced 3.9%	66,531 $5.02 Million
Q4 2017 Jan 16, 2018	BUY	$71.15 - $83.52 $3.71 Million - $4.35 Million	52,140 Added 305.09%	69,230 $4.96 Million
Q3 2017 Oct 12, 2017	BUY	$72.11 - $85.47 $1.23 Million - $1.46 Million	17,090	17,090 $1.39 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Account

Atria Investments LLC Gilead Sciences, Inc. Transaction History